David Katz

It is a good bit above what the Street was looking for. They raised their fundamental outlook.

However, most evidence suggests that the metabolic effects of sucrose and HFCS are pretty similar. What makes HFCS such a hazard is that corn growth is highly subsidized in the United States, so HFCS is very inexpensive - and thus a tempting additive to many foods.

There are far more satisfying explanations for epidemic obesity. We have more calories available per capita per day than ever before in history. And more and more of those calories are packaged in highly processed, flavor-enhanced, processed foods.

Our feeling has been and continues to be that there are going to be lots of home runs and strikeouts in technology. It's not a quarter-to-quarter-assured industry.

We think the stock is going to do very well. We like that industry. We think you have 40 percent upside on Applied.

Without any question, inflation will one day be out there. Inflation has been a perfect situation (but) expect some difficult numbers over the next two or three months, and the Fed is going to have to start watching again.

Not surprisingly, the disclosure of information about unsuspected paternity comes with potentially devastating effects.

The foundation believes the merger is not in their best interest and they have a big economic and equity interest.

Don't get fooled that way. Most people need to spend more time, especially when the market is going to be volatile, to study companies relative to industry norms and historic norms for valuation.

You don't know who's going to win until they actually win and by the time stocks react to that, it's too late.

We think that the rhetoric is going to be fairly negative and that is going to push prices of drug companies modestly lower over the short term. That's a very good time to be adding to positions. We think a year or two from now, not a lot is going to change and the drug companies are good growth businesses at more reasonable prices.

We think this is the cutting edge that's going to define how our products shape next generation networks, ... What happens here will be happening in other industries in a very short period of time.

They've grown earnings at about 15 percent a year for the last decade, ... They're always gaining market share. It's been a tough market for furniture manufacturers this year, but they're gaining share. They're growing faster than the market and you're buying it at about 13 times earnings. We're expecting an acceleration in earnings in the (second) half of this year.

Obesity is arguably the gravest public health threat in the United States today.

The market will take its cues from political events, Afghanistan events, ... stocks should start to trade higher.

On the Boston Scientific side the vote will be approved.

It's very important to remember that with the Dow at 8,000 -- with the market at about 22 or 23 times earnings -- there's just very little margin for safety. If anything in the economy, anything with inflation, anything with a world event goes wrong, you're going to see more downside than you normally would.

People who say obesity has been hyped are wrong.

I think Jackson and colleagues are likely to be wrong.

Looks like it's now going to be a race. Anybody that does not have a partner is going to be looking fast and hard to find a partner. a lot of people have had discussions over the last few years -- those discussions are going to accelerate.

January has historically been a better month in the market overall, especially pronounced in terms of companies that have had poor prior years -- after tax selling abates, they're due for a very strong bounce in January.

Three years ago, you had irrational exuberance, ... Currently you've got irrational despondency.

We think over the next six months Citigroup stock is going to have a very sharp rebound. So, if you've held on to it, stay with it. We don't think you're going to have to be terribly patient, ... Sometimes our investor choices might take two years. We think this is going to be a pretty short-term pop.

People covered by Medicare tend to have more health problems than younger people. But many of them can ill afford the medications they need. The result is that they may not take them, allowing readily controllable health problems to evolve into unmanaged crises.

We stay hungry longer the more diverse the flavors in a meal or snack. If flavors are thoughtfully distributed, we fill up on fewer calories. This explains why, for instance, people can eat a holiday meal to the point of feeling unpleasantly full, yet still have room for dessert. No, that's not because you have a 'hollow leg.' It's because of sensory specific satiety the hypothalamus is hard-wired to respond to flavors.